ELION THERAPEUTICS Trademark
Trademark Overview
On Thursday, May 23, 2024, a trademark application was filed for ELION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELION THERAPEUTICS trademark a serial number of 98566102. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, January 8, 2025. This trademark is owned by Elion Therapeutics, Inc.. The ELION THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease
General Information
| Serial Number | 98566102 |
| Word Mark | ELION THERAPEUTICS |
| Filing Date | Thursday, May 23, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, January 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 28, 2025 |
Trademark Statements
| Description of Mark | The mark consists of the word "ELION" in stylized curvilinear font with the word "THERAPEUTICS" in smaller all capitals immediately below justified to the right, both words being below three parallel broken lines with interlinear dots in a curved motif suggestive of a wave. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, January 10, 2024 |
| First Use In Commerce Date | Wednesday, January 10, 2024 |
Trademark Owner History
| Party Name | Elion Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10010 |
Trademark Events
| Event Date | Event Description |
| Thursday, May 23, 2024 | NEW APPLICATION ENTERED |
| Tuesday, December 3, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, December 3, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 17, 2024 | NON-FINAL ACTION WRITTEN |
| Sunday, December 8, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, December 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 7, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 22, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 17, 2024 | NON-FINAL ACTION E-MAILED |
